Sientra PT receives Investment Bank Analyst Rating Update
Investing.com - Sientra (NASDAQ:SIEN) Inc reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations. Sientra Inc...
Sientra (SIEN) reported Q3 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $22.6 million versus the consensus estimate of...
1. Bilibili Inc. (NASDAQ:BILI), a Chinese-style Youtube, with an explosive engulfing bar and V-bottom, on Tuesday jumped 1.56, or 4.63%, to 35.22, with a session and all-time high...
1. Aurora Cannabis Aurora Cannabis (NYSE:ACB) jumped 5.90, or 52.68%, to 17.10, after reaching a session high of 19.68, on 97 million shares traded, and another 1.49 to 18.58 in...
1. AbbVie (NYSE:ABBV), a biopharma research company, had a nice pop on Tuesday after reaching a session high of 92.23, and gaining 2.56, or 2.9%, to 90.46, on 22 million shares...
Sientra, Inc. is a medical aesthetics company focused on advancing the plastic surgery. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.
|Average||16.833 (+772.192% Upside)|
|No. of Analysts||3|